Ocker, M.; Mayr, C.; Kiesslich, T.; Stintzing, S.; Neureiter, D.
Immunmodulatory Treatment Strategies of Hepatocellular Carcinoma: From Checkpoint Inhibitors Now to an Integrated Approach in the Future. Cancers 2021, 13, 1558.
https://doi.org/10.3390/cancers13071558
AMA Style
Ocker M, Mayr C, Kiesslich T, Stintzing S, Neureiter D.
Immunmodulatory Treatment Strategies of Hepatocellular Carcinoma: From Checkpoint Inhibitors Now to an Integrated Approach in the Future. Cancers. 2021; 13(7):1558.
https://doi.org/10.3390/cancers13071558
Chicago/Turabian Style
Ocker, Matthias, Christian Mayr, Tobias Kiesslich, Sebastian Stintzing, and Daniel Neureiter.
2021. "Immunmodulatory Treatment Strategies of Hepatocellular Carcinoma: From Checkpoint Inhibitors Now to an Integrated Approach in the Future" Cancers 13, no. 7: 1558.
https://doi.org/10.3390/cancers13071558
APA Style
Ocker, M., Mayr, C., Kiesslich, T., Stintzing, S., & Neureiter, D.
(2021). Immunmodulatory Treatment Strategies of Hepatocellular Carcinoma: From Checkpoint Inhibitors Now to an Integrated Approach in the Future. Cancers, 13(7), 1558.
https://doi.org/10.3390/cancers13071558